Concepedia

Esther Wagena

EW

Statistics

Publications

9

Citations

535

H-Index

9

Active since

2009

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

The University of Texas MD Anderson Cancer Center

Radboud Institute for Molecular Life Sciences

Cancer Genomics Centre

Esther Wagena is an author at Radboud University Nijmegen specializing in oncology, cancer immunotherapy, and antitumor t cell responses.

Publications per year

2009–2024

9

Publications

9

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

Bettina Weigelin, Annemieke Th. den Boer, Esther Wagena et al. · Nature Communications · 2021 · 238 citations · Full text

Medicine, Cancer Biology, Oncology +16

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb

Bettina Weigelin, Elixabet Bolaños, Álvaro Teijeira et al. · Proceedings of the National Academy of Sciences · 2015 · 108 citations · Full text

Life Sciences, Immunology, Oncology +17

Baculovirus complementation restores a novel<i>NDUFAF2</i>mutation causing complex I deficiency

Saskia J.G. Hoefs, Cindy E. Dieteren, Richard J. Rodenburg et al. · Human Mutation · 2009 · 49 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall et al. · Cancer Immunology Immunotherapy · 2020 · 46 citations · Full text

Life Sciences, Immunology, Oncology +16

Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma

Julia Odenthal, Mark Rijpkema, Desirée L. Bos et al. · Scientific Reports · 2018 · 33 citations · Full text

Medicine, Cell Biology, Oncology +17

1–5 of 9